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Cells to Surgery Quiz
QUESTIONS
1. A patient presents to the clinic with the lesion pictured above. A somatic mutation in which of the following gene 
 products is most commonly seen in this disease?
a. BRAF.
b. NF1.
c. NRAS.
d. CDKN2A.
Cells to Surgery Quiz: October 2015
Adam S. Aldahan1, Stephanie Mlacker1, Vidhi V. Shah1, Sahal Samarkandy1, Mohammed Alsaidan1 and 
Keyvan Nouri1
Journal of Investigative Dermatology (2015) 135, e18. doi:10.1038/jid.2015.310
1Department of Dermatology and Cutaneous Surgery, University of Miami Miller School of Medicine, Miami, Florida, USA
Correspondence: Keyvan Nouri, Sylvester Comprehensive Cancer Center, UHealth–University of Miami Health System, 1475 NW 12th Avenue, Suite 2175, 
Miami, Florida 33136, USA. E-mail: knouri@med.miami.edu 
Image courtesy of Kavitha Reddy, Department of Dermatology, Boston University.
Questions relate to the image as well as to selected articles in JID, which are listed 
after the questions. Answers will be posted as supplementary material. We hope 
you enjoy this challenge.
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2. Excisional biopsy confirms the diagnosis of melanoma. The lesion is reported to be 0.8 mm in 
 thickness. Which of the following is the correct intervention?
a. Electrodesiccation and curettage.
b. Vemurafenib.
c. Wide excision with 1 cm margins.
d. Wide excision with 2 cm margins.
e. Wide excision with 2 cm margins + sentinel lymph node biopsy.
3. In previous studies, molecular analysis of BRAF-positive melanomas revealed heterogeneic 
 expression of BRAFV600. Riveiro-Falkenbach et al. analyzed BRAF-positive melanomas to assess 
 homogeneic and heterogeneic expression of BRAFV600. According to this study, what is the most 
 likely explanation for this heterogeneity?
a. Only a portion of the melanoma expresses the BRAFV600 mutation.
b. Technical errors in processing the sample.
c. The patient had two distinct melanomas, one positive for the BRAFV600 mutation and one 
 negative.
d. None of the above.
TOPIC ARTICLE
The questions refer to the following article:
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